Precision Medicine Research

Developments in precision medicine, genomics, and the understanding of the molecular characterization of cancer have launched a new era of cancer research and drug development. As the field of precision medicine progresses, Hoag will help lead the way.

Through research initiated at Hoag, as well as participation in clinical research studies with leading cancer centers and scientific researchers, Hoag is helping advance the field of precision medicine for the benefit of many. Clinical research and participation in registries help to standardize and collect outcomes data that can provide valuable information to other clinicians as well as build upon a body of evidence important for developing future treatments.

Hoag has initiated Precision Medicine research studies in the following areas:

  • Biomarker Research and Discovery
  • Whole-Body MRI Research Protocol for Patients with Germline TP53 Mutations
  • Precision Medicine Approach for Patients with Rare Cancers
  • Pharmacogenetics

Hoag collaborates with other leading institutions in Precision Medicine research in the following areas:

  • Circulating Tumor DNA in the Blood
  • Contributing to national registries with patients’ deidentified genomic information

Precision Medicine at Hoag

Hoag Family Cancer Institute continually works to provide the very best care for our patients. Hoag's Precision Medicine Program and its team of highly-regarded industry experts are a testament to that. No other hospital in Orange County provides this level of personalized cancer care.

Hoag's Precision Medicine team is here to support our oncology physicians and partners. If you are interested in precision medicine, we encourage you to speak with your physician. If deemed appropriate, your oncologist, or referring physician, will work directly with Hoag's Precision Medicine team to review your case and discuss next steps.